Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-045842

SVP & Chief Medical Officer sold 54,920 shares at $21.10 ($1,158,812)

  • SVP & Chief Medical Officer acquired 54,920 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gergel Ivan P. SVP & Chief Medical Officer 2017-07-18 Option exercise +54,920 $11.04 $606,317 98,492 D: show line 1 in the form
Gergel Ivan P. SVP & Chief Medical Officer 2017-07-18 Sale −54,920 $21.10 $1,158,812 43,572 D: show line 2 in the form
Open-market sales · 54,920 sh · avg $21.10 · $1,158,812

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Gergel Ivan P. SVP & Chief Medical Officer 2017-07-18 Option exercise · Stock Option −54,920 413,752 D: show line 3 in the form
Loading xslF345X03/doc4.xml…